![]() CLLS | Cellectis SA![]() Category: Company
Quick infos
Trade prices
Next ER: May 4, 2023 After Market ClosesAbout the CompanyCellectis is a French biopharmaceutical company. It develops genome-edited chimeric antigen receptor T-cell technologies for cancer immunotherapy. It has offices in Paris and New York City. Earnings History
NASDAQ - Nasdaq Stock Market More profiles and info about the company
NewsNews for (CLLS)
This company doesn't provide a dividend. Key Persons
Talk about Cellectis SA below in comments section below.Do you think you'll buy? Do you already have active trades now? EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. | NotesResearchInvestor pagewww.cellectis.comIf you are looking for News & events, Press Release, they are available on their Investors Relationssite.
Support this projectIf you want to help pay for server cost or for improving this tool. You can send it via Paypal. Social MediaRecommended Books![]() Buy on Amazon Currency Trading For Dummies is a hands-on, user-friendly guide that explains how the foreign exchange (ForEx) market works and how you can become a part of it. Currency trading has many benefits, but it also has fast-changing financial-trading avenues. ForEx markets are always moving. So how do you keep up? |